Evidence map›Paper›PMID 24452345›Full record

ArticleNature materials2014

A targeted approach to cancer imaging and therapy.

Chun Li

Abstract read
In one paragraph

Article in Nature materials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Nanomaterial-based contrast agents.Nature reviews. Methods primers · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Comprehensive comparison of theranostic nanoparticles in breast cancer.American journal of clinical and experimental immunology · 2022
    Review
  15. Article
  16. FePharmaceutics · 2021
    Article
  17. Review
  18. Hollow micro and nanostructures for therapeutic and imaging applications.Journal of drug delivery science and technology · 2020
    Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Chun LiDepartment of Cancer Systems Imaging-Unit 59, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Texas Center for Cancer NanomedicineU54CA151668 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LOGSDON, CRAIG D · 2010 to 2014
$12.4M
Near-Infrared Fluorescence Nanoparticles for Targeted Optical ImagingR01CA119387 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LI, CHUN · 2005 to 2009
$3.3M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA119387NCI NIH HHS R01CA119387NCI NIH HHS U54 CA151668NCI NIH HHS U54CA151668
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsContrast MediaDrug Delivery SystemsHumansImage EnhancementMolecular ImagingMolecular Targeted TherapyNanoparticlesNeoplasmsContrast Media

Identifiers

PMID24452345
PMCPMC4234179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.